|Articles|May 3, 2003

Several studies to provide new information, data about olopatadine

Four studies about olopatadine hydrochloride ophthalmic solution 0.1%(Patanol, Alcon Laboratories) and olopatadine hydrochloride ophthalmic solution0.2% (Patanol once-a-day) will be presented at ARVO, Alcon Laboratoriesannounced.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Latest CME